Long-Term Safety, Tolerability and Efficacy of Fesoterodine in Subjects with Overactive Bladder Symptoms Stratified by Age: Pooled Analysis of Two Open-Label Extension Studies

Author： Sand Peter K.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.29, Iss.2, 2012-02, pp. : 119-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

By Rogers S.L.   Doody R.S.   Pratt R.D.   Ieni J.R.  

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

By Rogers S.L.   Friedhoff L.T.  

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Long-Term Efficacy and Tolerability of a Fixed-Dose Combination of Antihypertensive Agents: An Open-Label Surveillance Study in China

By Wu Yiqun   Hu Yonghua   Tang Xun   He Liu   Ren Tao   Tao Qiushan   Qin Xueying   Sun Ningling  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 769-777

Adis International

Access to resources Recommend Favorite

Tolerability and Safety of Topiramate in Chinese Patients with Epilepsy: An Open-Label, Long-Term, Prospective Study

By Lu Yang  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 683-690

Adis International

Access to resources Recommend Favorite

Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase

By Sica Domenic  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite